HFS
PDSB icon

Hughes Financial Services’s PDS Biotechnology PDSB Stock Holding History

Hughes Financial Services’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-764
Closed -$825 – 1185
2025
Q1 		$825 Buy
+764
New +$1.09K ﹤0.01% 745

Other funds holding PDSB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hughes Financial Services's PDSB Position: Q2 2025 in Review

Hughes Financial Services sold out of PDS Biotechnology (PDSB) in Q2 2025, closing a stake of 764 shares — an estimated $825 sold.

Hughes Financial Services first reported a position in PDSB in Q1 2025 and held it in 1 quarter. The position peaked at $825 in Q1 2025. 55 funds tracked by Wall St. Rank hold PDSB as of Q2 2025.

  • Hughes Financial Services reported no remaining PDS Biotechnology position as of Q2 2025 after selling out during the quarter.
  • Hughes Financial Services sold 764 PDS Biotechnology shares in Q2 2025, an estimated $825.
  • Hughes Financial Services first reported a position in PDS Biotechnology in Q1 2025 and held it in 1 quarter.
  • Hughes Financial Services's PDS Biotechnology position peaked at $825 in Q1 2025.
  • 55 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2025.

Based on Hughes Financial Services's 13F filing for Q2 2025, filed 7 Aug 2025.